Home / Sport rules and injury care both count.
Sport rules and injury care both count.
Wanting to get back is easy to understand. The recovery claim still has to hold up, and the sport rules still apply.
The restriction follows the substance off the field
The 2026 World Anti-Doping Agency list bans BPC-157 and TB-500 at all times. For athletes covered by these rules, that includes time away from competition. A break from playing is not a break from these rules.
A ban also does not prove that a substance helps recovery. It is a rule about what is allowed in sport. The missing evidence about human muscle injury stays missing, however often the ban is offered as proof that a peptide must work.
The National Collegiate Athletic Association’s 2026–27 list names both too. College sport has its own rules. The 2027 world list takes over on January 1, 2027; the 2026 list remains in force through December 31, 2026. The relevant governing body can settle which rules apply to a competition.
A withdrawn request is not clearance
On FDA’s page current as of April 22, 2026, BPC-157 and the TB-500 fragment are listed as nominated but withdrawn. In plain words, the groups that asked FDA to consider these ingredients for compounding took their requests back. Compounding means making a medicine by mixing or changing its ingredients.
They are no longer in that page's Category 2 table, the group flagged for significant safety risks. FDA still prints its safety concerns beside them. Withdrawal does not mean clearance, a move to Category 1 or approval for compounding. Category 1 is a separate group under review, not an approval either.
For the July 2026 review, FDA staff proposed against adding BPC-157 to the permitted compounding-ingredient list, and proposed against adding TB-500. That's a staff recommendation, not a committee vote or final rule. FDA gives no date for either substance’s move to the withdrawn table.
An appointment is for an assessment
A licensed clinician can assess an injury and discuss lawful care. That is not a promise of a BPC-157 or TB-500 prescription.
Bring the injury into the conversation
I'd bring the task that matters: stairs, lifting at work or returning to a sport. A licensed U.S. clinician can assess the problem and discuss lawful care, including FDA-approved options where they exist. Compounded medicines are not FDA-approved.
For TB-500 injections, FDA identifies germs, bacterial toxins and stray particles as safety concerns. A high purity figure cannot settle those questions.
Medical-board model guidance holds remote care to the same standard as care in person, including arranging an examination or tests when needed. Telehealth does not change which ingredients may be compounded. This is general information, not medical or legal advice.